Ignite Creation Date:
2024-05-05 @ 4:41 PM
Last Modification Date:
2024-10-26 @ 9:22 AM
Study NCT ID:
NCT00290498
Status:
COMPLETED
Last Update Posted:
2020-06-02
First Post:
2006-02-10
Brief Title:
Study of Rituximab-HCVAD Alternating With Rituximab-Methotrexate-Cytarabine Versus Standard Rituximab-CHOP Every 21 Days for Patients With Newly Diagnosed High Risk Aggressive B-Cell Non-Hodgkins Lymphomas in Patients 60 Years Old or Younger
Sponsor:
Organization:
MD Anderson Cancer Center